KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc., the industry leader in discovery and development of biased GPCR ligands, announced today that Maxine Gowen, Ph.D., president and chief executive officer of Trevena, will make a presentation at the 13th annual BIO CEO and Investor Conference in New York next week. Dr Gowen will address the conference at 8:00am on Tuesday February 15th.
